Fycompa® is an original prescription antiepileptic medicine manufactured by Eisai. It contains Perampanel, a selective non-competitive AMPA receptor antagonist used for the treatment of several types of epilepsy in adolescents and adults.
Perampanel helps reduce excessive neuronal excitation in the brain, decreasing seizure frequency and improving seizure control when used as prescribed.
Fycompa is available in multiple strengths, allowing physicians to tailor treatment according to individual patient needs.
Perampanel
Available strengths:
Dosage form: Film-coated tablets.
Fycompa is indicated for the treatment of:
Perampanel selectively blocks AMPA glutamate receptors involved in excitatory neurotransmission.
This mechanism helps:
Common adverse effects may include:
Patients should consult their healthcare provider if significant side effects occur.
Fycompa should not be used in patients with:
Use cautiously in patients with liver disease, kidney impairment, or psychiatric disorders.
Fycompa is generally taken once daily, preferably at bedtime.
The dosage should be increased gradually under physician supervision.
Do not discontinue treatment abruptly without medical advice.
Store:
Fycompa is used to treat various forms of epilepsy and help reduce seizure frequency.
Perampanel.
Usually once daily, preferably in the evening.
2 mg (7 and 28 tablets), 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg.
No. Treatment should only be discontinued gradually under medical supervision.
Yes. Fycompa is the original Perampanel product manufactured by Eisai.
Ask a question or inquire about delivery to your country